MariMed Inc. (OTCMKTS:MRMD) Short Interest Update

MariMed Inc. (OTCMKTS:MRMDGet Free Report) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totaling 36,003 shares, a decrease of 45.2% from the March 31st total of 65,750 shares. Based on an average daily volume of 1,232,829 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of MariMed from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

View Our Latest Analysis on MRMD

MariMed Trading Down 0.6%

Shares of MRMD stock traded down $0.00 during trading hours on Monday, reaching $0.08. 247,416 shares of the stock traded hands, compared to its average volume of 523,015. MariMed has a 1-year low of $0.06 and a 1-year high of $0.23. The business has a fifty day moving average price of $0.08 and a 200 day moving average price of $0.09. The company has a quick ratio of 0.38, a current ratio of 1.00 and a debt-to-equity ratio of 1.44. The firm has a market capitalization of $31.31 million, a PE ratio of -2.62 and a beta of 1.15.

About MariMed

(Get Free Report)

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.

Read More

Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.